Vitarine Pharmaceuticals
As of the edition of 20 October 2026, Vitarine Pharmaceuticals runs 7 drugs, 7 of them marketed.
Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.
Drugs by status
| Status | Count |
|---|---|
| Marketed | 7 |
| Total | 7 |
Marketed drugs and when their US protection ends
| Drug | US protection | Route B rows |
|---|---|---|
| Metronidazole | none listed | 0 |
| Furosemide | none listed | 2 |
| Isoniazid | none listed | 0 |
| Methadone | none listed | 2 |
| Tolbutamide | none listed | 0 |
| Reserpine | none listed | 0 |
| Phendimetrazine | none listed | 0 |
A route B row is one company at one target.